Global X HLTH Care Cov CallHYLGETF

13F holders, Q2 2024 (June 30)
4holders +1
2new positions
1sold out
$25.34avg. 13F price*

At the end of Q2 2024, 4 institutions reported holding Global X HLTH Care Cov Call (HYLG) in their 13F filings, up 1 from Q1 2024. 2 opened new positions and 1 sold out. The largest holders were Cambridge Investment Research Advisors, Inc. ($219K), National Bank of Canada ($20K) and Royal Bank of Canada ($13K).

Company
Global X HLTH Care Cov Call
CUSIP
37960A750
Latest filing quarter
Q4 2024

History

Number of 13F holders

01234 Q1 2024: 3Q1 2024Q2 2024: 4Q2 2024Q3 2024: 4Q3 2024Q4 2024: 3Q4 2024

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions2$20K
Exits1$204K

All 13F filers, Q1 2024 → Q2 2024: 792 shares bought and 9,025 shares sold, net −8,233 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

Cambridge Investment Research Advisors, Inc. 0.00% Reduce -11.7% 8,651 $219K
National Bank of Canada 0.00% New 789 $20K
Royal Bank of Canada 0.00% No change 500 $13K
Morgan Stanley 0.00% New 3 $92

"% of holder's portfolio" is HYLG's weight in each manager's 13F, not the share of Global X HLTH Care Cov Call the manager owns.